Arcutis Biotherapeutics Inc. (ARQT)
NASDAQ · Healthcare
Arcutis Biotherapeutics Inc. Shareholder Equity 2020–2025
Arcutis Biotherapeutics Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Arcutis Biotherapeutics Inc. shareholder equity as of December 31, 2025: 189.5M, a 20.27% increase year-over-year.
- Arcutis Biotherapeutics Inc. shareholder equity for 2025 were 189.5M, a 20.27% increase from 2024.
- Arcutis Biotherapeutics Inc. shareholder equity for 2024 were 157.5M, a 77.68% increase from 2023.
- Arcutis Biotherapeutics Inc. shareholder equity for 2023 were 88.7M, a 57.69% decrease from 2022.
- Arcutis Biotherapeutics Inc. shareholder equity for 2022 were 209.6M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Arcutis Biotherapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $189 |
| 2024 | $158 |
| 2023 | $89 |
| 2022 | $210 |
| 2021 | $298 |
| 2020 | $271 |
Arcutis Biotherapeutics Inc. Shareholder Equity — FAQ
Arcutis Biotherapeutics Inc. (ARQT) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARQT's shareholder equity history?
The chart and table above show Arcutis Biotherapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.